The full content of Annals is available to subscribers

Subscribe/Learn More  >
Ideas and Opinions |

Learning from Our Patients: One Participant's Impact on Clinical Trial Research and Informed Consent

Christopher K. Daugherty, MD; Mark Siegler, MD; Mark J. Ratain, MD; and George Zimmer, PhD
[+] Article, Author, and Disclosure Information

From the University of Chicago, Chicago, Illinois. Acknowledgment: The authors thank the widow of Professor Zimmer, Mrs. Barbara Zimmer, for granting permission to publish his essay. Grant Support: By grant PRTA-24 from the American Cancer Society; the MacLean Center for Clinical Medical Ethics; the Pew Charitable Trust; the Henry J. Kaiser Family Foundation; the Andrew W. Mellon Foundation; and public health service contract NO1-CMO7301 from the National Cancer Institute, National Institutes of Health, and U.S. Department of Health and Human Services. Requests for Reprints: Christopher Daugherty, MD, Section of Hematology/Oncology, The MacLean Center for Clinical Medical Ethics, MC-2115, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637-1470. Current Author Addresses: Dr. Daugherty: Section of Hematology/Oncology, The MacLean Center for Clinical Medical Ethics, MC-2115, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1997;126(11):892-897. doi:10.7326/0003-4819-126-11-199706010-00008
Text Size: A A A

This Perspective includes an essay on modifying phase I clinical trials, written by George Zimmer, who was a professor of English and a commentary on that essay.Professor Zimmer was a cancer patient who participated in the phase I clinical trial program at the University of Chicago. His ideas are eloquently expressed and have had a profound effect on our investigational research for anticancer agents. Although at times his suggestions may seem radical, Professor Zimmer urges us to reconsider the 50-year-old Nuremberg paradigm that participants in human research are ignorant and vulnerable and must be protected. Although we must protect patients who have life-threatening diseases from coercive inducements and misplaced hopes, we must also listen carefully and thoughtfully to our patients. This is particularly true when, as research participants in the face of sacrifice and the threat of a life-ending diagnosis, they have made the effort to express their concerns. With the effect of the acquired immunodeficiency syndrome movement on clinical studies and on drug research and development, a precedent has been set that allows patients to reshape their role as participants in research trials. On a personal level, the essay by Professor Zimmer has had a significant effect on our research methods and, indeed, the focus of our research efforts. Thus, it is with a sense of respect and honor that we share George Zimmer's thoughts and our comments about the influence he has had on our research practices.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.